Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing

Press Release – New York, NY – October 15, 2019 – Sichenzia Ross Ference LLP founding partner Gregory Sichenzia will join representatives of client Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical stage, specialty pharmaceutical company, focused on treatment solutions for depression, CNS and ophthalmological disorders, at the Nasdaq MarketSite in Times Square to ring the October 18 opening bell.

Mr. Sichenzia will take the stage along with a group of Relmada Therapeutics leaders, including Chief Executive Officer Sergio Traversa, PharmD, MBA. You can tune in October 18 at 9:30am EST on Facebook Live or via the Nasdaq Webcam.